Nephrocalcinosis Clinical Trial
Official title:
Prevalence and Risk Factors of Nephrocalcinosis in Children at Sohag University Hospital
To study prevalence, risk factors, possible etiologies, clinical presentation and outcome of nephrocalcinosis in children at Sohag University Hospital.
Status | Not yet recruiting |
Enrollment | 50 |
Est. completion date | May 2024 |
Est. primary completion date | May 2024 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 1 Month to 12 Years |
Eligibility | Inclusion Criteria: - • All patients aged from one month to 12 years diagnosed with nephrocalcinosis at pediatric department and nephrology outpatient clinic. Exclusion Criteria: - • Children with nephrolithiasis without nephrocalcinosis. |
Country | Name | City | State |
---|---|---|---|
n/a |
Lead Sponsor | Collaborator |
---|---|
Sohag University |
Habbig S, Beck BB, Hoppe B. Nephrocalcinosis and urolithiasis in children. Kidney Int. 2011 Dec;80(12):1278-91. doi: 10.1038/ki.2011.336. Epub 2011 Sep 28. Erratum In: Kidney Int. 2012 Aug;82(4):493-7. — View Citation
Hoppe B, Martin-Higueras C, Younsi N, Stein R. [Nephrolithiasis and nephrocalcinosis in children and adolescents]. Urologie. 2022 Oct;61(10):1099-1109. doi: 10.1007/s00120-022-01888-3. Epub 2022 Jul 8. German. — View Citation
Monet-Didailler C, Chateil JF, Allard L, Godron-Dubrasquet A, Harambat J. [Nephrocalcinosis in children]. Nephrol Ther. 2021 Feb;17(1):58-66. doi: 10.1016/j.nephro.2020.12.001. Epub 2021 Jan 15. French. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | percentage of nephrocalcinosis among renal diseases | percentage of children presented with nephrocalcinosis among all children with renal diseses in sohag university hospital | one year | |
Secondary | Percentage of each risk factor of Nephrocalcinosis | percentage of each risk factor related to Nephrocalcinosis in children in ssohag univesity hospital | one year |
Status | Clinical Trial | Phase | |
---|---|---|---|
Withdrawn |
NCT00875823 -
International Registry for Primary Hyperoxaluria
|
N/A | |
Completed |
NCT04382976 -
The Incidence and the Risk Factors of Nephrocalcinosis in Very Preterm Infants
|
||
Completed |
NCT00249951 -
Alkaline Citrate Treatment to Lower the Risk of Nephrocalcinosis in Preterm Infants
|
Phase 3 | |
Recruiting |
NCT00169806 -
Randall's Plaque Study: Pathogenesis and Relationship to Nephrolithiasis
|
N/A | |
Not yet recruiting |
NCT01756547 -
Study to Assess the Efficacy and Safety of Oral Potassium Citrate on the Prevention of Nephrocalcinosis in Extreme Premature
|
Phase 3 | |
Active, not recruiting |
NCT04495608 -
Multicenter, Double-blind, Placebo-controlled Study to Evaluate the Efficacy and Safety of Fluconazole in Hypercalcicuric Patients With Increased 1.25(OH) 2D Levels
|
Phase 2 | |
Completed |
NCT02438267 -
Preterm Infants and Nephrocalcinosis
|
N/A |